Ribosomal protein S20 pseudogene 31 (RPS20P31)

Ribosomal protein S20 pseudogene 31 (RPS20P31) is a processed pseudogene in the human genome, not a protein-coding gene or functional molecule. It is derived from the ribosomal protein S20 (RPS20), a component of the 40S ribosomal subunit, but RPS20P31 itself does not encode a functional protein and is considered a non-functional genomic remnant[2][4][6]. Pseudogenes like RPS20P31 typically arise through reverse transcription and insertion events; they are often truncated and may be associated with retrotransposons[5]. There is no evidence supporting a role for RPS20P31 as a therapeutic target, enzyme, receptor, or biomarker, nor association with disease or drug interaction[2][4][8].\n\nKey points:\n- **RPS20P31** is a pseudogene and does not produce a functional protein[2][4].\n- It is not considered a therapeutic target, nor does it have known biological functions, disease associations, or known safety concerns.\n- The gene is synonymous with "RPS20_15_1287"[6].\n- There may be confusion as genuine targets are usually annotated as "RPS20" (ribosomal protein S20), which is a coding gene and ribosomal protein involved in translation, whereas RPS20P31 is explicitly a pseudogene[2][6][7][10].\n\n**Note:**\nThis entry is commonly misinterpreted as a protein-coding gene; in reality, it is a pseudogene and should not be categorized under standard drug target classes. Considerable information is missing for several requested fields, as pseudogenes do not have functions, drug interactions, or clinical relevance except in certain rare regulatory or disease contexts, none of which are documented for RPS20P31[4][5][8].

Other names

RPS20_15_1287RPS20P31